311 related articles for article (PubMed ID: 21849891)
1. Oral azithromycin for treatment of posterior blepharitis.
Igami TZ; Holzchuh R; Osaki TH; Santo RM; Kara-Jose N; Hida RY
Cornea; 2011 Oct; 30(10):1145-9. PubMed ID: 21849891
[TBL] [Abstract][Full Text] [Related]
2. Multicenter open-label study evaluating the efficacy of azithromycin ophthalmic solution 1% on the signs and symptoms of subjects with blepharitis.
Haque RM; Torkildsen GL; Brubaker K; Zink RC; Kowalski RP; Mah FS; Pflugfelder SC
Cornea; 2010 Aug; 29(8):871-7. PubMed ID: 20508503
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of azithromycin 1% ophthalmic solution for treatment of ocular surface disease from posterior blepharitis.
Opitz DL; Tyler KF
Clin Exp Optom; 2011 Mar; 94(2):200-6. PubMed ID: 21083761
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of topical azithromycin ophthalmic solution 1% in the treatment of posterior blepharitis.
Luchs J
Adv Ther; 2008 Sep; 25(9):858-70. PubMed ID: 18781287
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the Clinical Efficacy of Topical and Systemic Azithromycin Treatment for Posterior Blepharitis.
Yildiz E; Yenerel NM; Turan-Yardimci A; Erkan M; Gunes P
J Ocul Pharmacol Ther; 2018 May; 34(4):365-372. PubMed ID: 29493395
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of clinical efficacy and safety of tobramycin/dexamethasone ophthalmic suspension 0.3%/0.05% compared to azithromycin ophthalmic solution 1% in the treatment of moderate to severe acute blepharitis/blepharoconjunctivitis.
Torkildsen GL; Cockrum P; Meier E; Hammonds WM; Silverstein B; Silverstein S
Curr Med Res Opin; 2011 Jan; 27(1):171-8. PubMed ID: 21138337
[TBL] [Abstract][Full Text] [Related]
7. Correlations among symptoms, signs, and clinical tests in evaporative-type dry eye disease caused by Meibomian gland dysfunction (MGD).
Cuevas M; González-García MJ; Castellanos E; Quispaya R; Parra Pde L; Fernández I; Calonge M
Curr Eye Res; 2012 Oct; 37(10):855-63. PubMed ID: 22632103
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of a new warm moist air device on tear functions of patients with simple meibomian gland dysfunction.
Matsumoto Y; Dogru M; Goto E; Ishida R; Kojima T; Onguchi T; Yagi Y; Shimazaki J; Tsubota K
Cornea; 2006 Jul; 25(6):644-50. PubMed ID: 17077654
[TBL] [Abstract][Full Text] [Related]
9. Minocycline controls clinical outcomes and inflammatory cytokines in moderate and severe meibomian gland dysfunction.
Lee H; Min K; Kim EK; Kim TI
Am J Ophthalmol; 2012 Dec; 154(6):949-957.e1. PubMed ID: 22967863
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Azithromycin Eyedrops for Individuals With Meibomian Gland Dysfunction-Associated Posterior Blepharitis.
Arita R; Fukuoka S
Eye Contact Lens; 2021 Jan; 47(1):54-59. PubMed ID: 32649390
[TBL] [Abstract][Full Text] [Related]
11. Oral azithromycin for the treatment of meibomitis.
Greene JB; Jeng BH; Fintelmann RE; Margolis TP
JAMA Ophthalmol; 2014 Jan; 132(1):121-2. PubMed ID: 24201556
[No Abstract] [Full Text] [Related]
12. Use of azithromycin ophthalmic solution in the treatment of chronic mixed anterior blepharitis.
John T; Shah AA
Ann Ophthalmol (Skokie); 2008; 40(2):68-74. PubMed ID: 19013912
[TBL] [Abstract][Full Text] [Related]
13. Correlation of tear fluorescein clearance and Schirmer test scores with ocular irritation symptoms.
Afonso AA; Monroy D; Stern ME; Feuer WJ; Tseng SC; Pflugfelder SC
Ophthalmology; 1999 Apr; 106(4):803-10. PubMed ID: 10201606
[TBL] [Abstract][Full Text] [Related]
14. Effect of oral linoleic and gamma-linolenic acid on meibomian gland dysfunction.
Pinna A; Piccinini P; Carta F
Cornea; 2007 Apr; 26(3):260-4. PubMed ID: 17413949
[TBL] [Abstract][Full Text] [Related]
15. Eyelid margin modification associated with eyelid hygiene in anterior blepharitis and meibomian gland dysfunction.
Guillon M; Maissa C; Wong S
Eye Contact Lens; 2012 Sep; 38(5):319-25. PubMed ID: 22890229
[TBL] [Abstract][Full Text] [Related]
16. Current evidence for topical azithromycin 1% ophthalmic solution in the treatment of blepharitis and blepharitis-associated ocular dryness.
Veldman P; Colby K
Int Ophthalmol Clin; 2011; 51(4):43-52. PubMed ID: 21897139
[No Abstract] [Full Text] [Related]
17. Changes in meibomian fatty acids and clinical signs in patients with meibomian gland dysfunction after minocycline treatment.
Souchier M; Joffre C; Grégoire S; Bretillon L; Muselier A; Acar N; Beynat J; Bron A; D'Athis P; Creuzot-Garcher C
Br J Ophthalmol; 2008 Jun; 92(6):819-22. PubMed ID: 18511542
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of moxifloxacin-dexamethasone eyedrops as treatment for bacterial ocular infection associated with bacterial blepharitis.
Belfort R; Gabriel L; Martins Bispo PJ; Muccioli C; Zacharias Serapicos PC; Clark L; Bell B; Bartell J; Stroman DW; Höfling-Lima AL
Adv Ther; 2012 May; 29(5):416-26. PubMed ID: 22562783
[TBL] [Abstract][Full Text] [Related]
19. Assessment of efficacy of topical azithromycin 1.5 per cent ophthalmic solution for the treatment of meibomian gland dysfunction.
Balci O; Gulkilik G
Clin Exp Optom; 2018 Jan; 101(1):18-22. PubMed ID: 28677153
[TBL] [Abstract][Full Text] [Related]
20. Conjunctival impression cytology, ocular surface, and tear-film changes in patients treated with systemic isotretinoin.
Karalezli A; Borazan M; Altinors DD; Dursun R; Kiyici H; Akova YA
Cornea; 2009 Jan; 28(1):46-50. PubMed ID: 19092405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
